Functional disorder of primary immunity responding to respiratory syncytial virus infection in offspring mice exposed to a flame retardant, decabrominated diphenyl ether, perinatally

Journal of Medical Virology

Volumn 82, Issue 6, 2010, Pages 1075-1082

  Watanabe, Wataru ^a   Shimizu, Tomomi ^a   Sawamura, Rie ^a   Hino, Akane ^a   Konno, Katsuhiko ^a   Kurokawa, Masahiko ^a  

^a KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Decabrominated diphenyl ether; Innate pattern recognition receptors; Macrophages; Respiratory syncytial virus; TNF

Indexed keywords

CYTOKINE; DIPHENYL ETHER; FLAME RETARDANT; INTERLEUKIN 6; MELANOMA DIFFERENTIATION ASSOCIATED GENE 5; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BROMINATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FUNCTIONAL DISEASE; GENE EXPRESSION; IMMUNE RESPONSE; LUNG LAVAGE; LUNG PARENCHYMA; MACROPHAGE; MALE; MOUSE; NONHUMAN; PERINATAL PERIOD; PROGENY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INFECTION; VIRUS TITRATION;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; FEMALE; FLAME RETARDANTS; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS; LUNG; MALE; MICE; MICE, INBRED BALB C; ORGAN CULTURE TECHNIQUES; PHENYL ETHERS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES;

MUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 77953494560     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21770     Document Type: Article

References (37)

1. Birnbaum LS, Staskal DF. 2004. Brominated flame retardants: Cause for concern? Environ Health Perspect 112:9-17.
2. Ceccatelli R, Faass O, Schlumpf M, Lichtensteiger W. 2006. Gene expression and estrogen sensitivity in rat uterus after developmental exposure to the polybrominated diphenylether PBDE 99 and PCB. Toxicology 220:104-116.
3. Collins PL, Chanock RM, Murphy BR. 2001. Respiratory syncytial virus. In: Knipe DM, Howley PM, editors. Fields virology. Philadelphia, PA: Lippincott Williams&Wilkins. pp 1443-1485.
4. Eriksson P, Viberg H, Jakobsson E, Örn U, Fredriksson A. 2002. A brominated flame retardant, 2, 20, 4, 40, 5-pentabromodiphenyl ether: Uptake, retention, and induction of neurobehavioral alterations inmice during a critical phase of neonatal brain development. Toxicol Sci 67:98-103.
5. Fischer D, Hooper K, Athanasiadou M, Athanassiadis I, Bergman A. 2006. Children show highest levels of polybrominated diphenyl ethers in a California family of four: A case study. Environ Health Perspect 114:1581-1584.
6. Fowles JR, Fairbrother A, Baecher-Steppan L, Kerkvliet NI. 1994. Immunologic and endocrine effects of the flame-retardant pentabromodiphenyl ether (DE-71) in C57BL/6J mice. Toxicology 86:49-61.
7. Franchi L, Eigenbrod T, Muňoz-Planillo R, Nuňez G. 2009. The inflammasome: A caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 10: 241-247.
8. Gordon SB, Read RC. 2002. Macrophage defences against respiratory tract infections. Br Med Bull 61:45-61.
9. Hall CB, Douglas RG, Jr., Simons RL. 1981. Interferon production in adults with respiratory syncytial viral infection. Ann Intern Med 94:53-55.
10. Haynes LM, Moore DD, Kurt-Jones EA, Finberg RW, Anderson LJ, Tripp RA. 2001. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol 75:10730-10737.
11. Hedemalm P, Carisson P, Palm V. 1995. Waste from electrical and electronic products - A survey of the contents of materials and hazardous substances in electric and electronic products. Tema Nord 554 Copenhagen: Nordic Council of Ministers.
12. Holberg CJ, Wright AL, Martinez FD, Ray CG, Taussig LM, Lebowitz MD. 1991. Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life. Am J Epidemiol 133:1135-1151.
13. Hussell T, Openshaw PJ. 1998. Intracellular IFN-gamma expression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection. J Gen Virol 79:2593-2601.
14. Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A. 2009. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med 206:79-87.
15. Janeway CA, Travers P, Walport M, Shlomchik MJ. 2001. Innate immunity. Immunobiology: The immune system in health and disease, 5th edition. New York, NY: Garland Publishing. pp 35-91.
16. Kuriyama SN, Wanner A, Fidalgo-Neto AA, Talsness CE, Koerner W, Chahoud I. 2007. Developmental exposure to low-dose PBDE-99: Tissue distribution and thyroid hormone levels. Toxicology 242: 80-90.
17. Kurokawa M, Tsurita M, Brown J, Fukuda Y, Shiraki K. 2002. Effect of interleukin-12 level augmented by Kakkon-to, a herbal medicine, on the early stage of influenza infection in mice. Antiviral Res 56:183-188.
18. Kurokawa M, Brown J, Kagawa Y, Shiraki K. 2003. Cytokine-regulatory activity and therapeutic efficacy of cinnamyl derivatives in endotoxin shock. Eur J Pharmacol 474:283-293.
19. Lilienthal H, Hack A, Roth-Härer A, Grande SW, Talsness CE. 2006. Effects of developmental exposure to 2, 2′, 4, 4′, 5-pentabromodiphenyl ether (PBDE-99) on sex steroids, sexual development, and sexually dimorphic behavior in rats. Environ Health Perspect 114:194-201.
20. Lundgren M, Darnerud PO, Molin Y, Lilienthal H, Blomberg J, Ilbäck NG. 2007. Viral infection and PBDE exposure interact on CYP gene expression and enzyme activities in the mouse liver. Toxicology 242:100-108.
21. Lundgren M, Darnerud PO, Blomberg J, Friman G, Ilbäck NG. 2009. Polybrominated diphenyl ether exposure suppresses cytokines important in the defence to coxsackievirus B3 infection in mice. Toxicol Lett 184:107-113.
22. MacDonald NE, Hall CB, Suffin SC, Alexson C, Harris PJ, Manning JA. 1982. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med 307:397-400.
23. Martin PA, Mayne GJ, Bursian FS, Tomy G, Palace V, Pekarik C, Smits J. 2007. Immunotoxicity of the commercial polybrominated diphenyl ether mixture DE-71 in ranch mink (Mustela vison). Environ Toxicol Chem 26:988-997.
24. Masutomi N, Shibutani M, Takagi H, Uneyama C, Hirose M. 2004. Dietary influence on the impact of ethinylestradiol-induced alterations in the endocrine/reproductive system with perinatal maternal exposure. Reprod Toxicol 18:23-33.
25. McDonald TA. 2005. Polybrominated diphenylether levels among United States residents: Daily intake and risk of harm to the developing brain and reproductive organs. Integr Environ Assess Manag 1:343-354.
26. Morales F, Calder MA, Inglis JM, Murdoch PS, Williamson J. 1983. A study of respiratory infections in the elderly to assess the role of respiratory syncytial virus. J Infect 7:236-247.
27. Mörck A, Hakk H, Orn U, Klasson-Wehler E. 2003. Decabromodiphenyl ether in the rat: Absorption, distribution, metabolism and excretion. Drug Metab Dispos 31:900-907.
28. Nagano M, Yamashita T, Hamada H, Ohneda K, Kimura K, Nakagawa T, Shibuya M, Yoshikawa H, Ohneda O. 2007. Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood. Blood 110:151-160.
29. National Toxicology Program. 1986. NTP toxicology and carcinogenesis studies of decabromodiphenyl oxide (CAS No. 1163-19-5) in F344/N rats and B6C3F1 mice (feed studies). Natl Toxicol Program Tech Rep Ser 309:1-242.
30. Neuzil KM, Tang YW, Graham BS. 1996. Protective role of TNF-alpha in respiratory syncytial virus infection in vitro and in vivo. Am J Med Sci 311:201-204.
31. Reistad T, Mariussen E. 2005. Acommercial mixture of the brominated flame retardant pentabrominated diphenyl ether (DE-71) induces respiratory burst in human neutrophil granulocytes in vitro. Toxicol Sci 87:57-65.
32. Shinohara T, Inoue K, Ogonuki N, Kanatsu-Shinohara M, Miki H, Nakata K, Kurome M, Nagashima H, Toyokuni S, Kogishi K, Honjo T, Ogura A. 2002. Birth of offspring following transplantation of cryopreserved immature testicular pieces and in-vitro microinsemination. Hum Reprod 17:3039-3045.
33. Teshima R, Nakamura R, Nakamura R, Hachisuka A, Sawada J, Shibutani M. 2008. Effects of exposure to decabromodiphenyl ether on the development of the immune system in rats. J Health Sci 54:382-389.
34. Viberg H, Fredriksson A, Jakobsson E, Örn U, Eriksson P. 2003. Neurobehavioral derangements in adult mice receiving decabrominated diphenyl ether (PBDE 209) during a defined period of neonatal brain development. Toxicol Sci 76:112-120.
35. Watanabe W, Shimizu T, Hino A, Kurokawa M. 2008a. A new assay system for evaluation of developmental immunotoxicity of chemical compounds using respiratory syncytial virus infection to offspring mice. Environ Toxicol Pharmacol 25:69-74.
36. Watanabe W, Shimizu T, Hino A, Kurokawa M. 2008b. Effects of decabrominated diphenyl ether (DBDE) on developmental immunotoxicity in offspring mice. Environ Toxicol Pharmacol 26:315-319.
37. Zhou T, Ross DG, DeVito MJ, Crofton KM. 2001. Effects of short-term in vivo exposure to polybrominated diphenyl ethers on thyroid hormones and hepatic enzyme activities in weanling rats. Toxicol Sci 61:76-82.